# WhiteLab Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/whitelab-genomics

- Industry: Biotechnology
- Headquarters: Evry-courcouronnes, France
- Website: www.whitelabgx.com
- Total disclosed funding: $29M
- Latest round: Series B (Oct 6, 2026)
- Investors on record: 6

## About

Based in France, and founded in 2019, WhiteLab Genomics SAS develops genomic medicine through machine learning and deep learning algorithms. The company was founded by its CEO David Del Bourgo, and CSO Julien Cottineau. In October 2026, WhiteLab Genomics SAS raised EUR 23.2 million in series B funding led by new investor AXA Venture Partners, with participation from other new investor Blast.Club and Yaday. Returning investors Debiopharm Innovation Fund and Omnes Capital. Whitelab Genomics develops, designs, and offers various genomic therapies, including DNA, cell therapy, and RNA therapies, with the help of machine learning and deep learning algorithms. The company offers its software solutions and genomic therapies in the applications of target discovery, payload design, and vector design. The company’s artificial intelligence (AI) engine uses datasets to provide in-silico predictions. The company plans to use the funds raised in October 2026 to expand in vivo testing, develop non-viral delivery technologies, strengthen its North American presence, and build partnerships with biopharma companies.

## Funding rounds

- Series B, Oct 6, 2026, $26M — Omnes Capital, AXA Venture Partners, Debiopharm Innovation Fund, Yaday, Blast.Club
- Series A, Apr 21, 2023, $2.7M — Omnes Capital, Debiopharm Group

## Investors

- Omnes Capital (https://capitalatlas.ai/funds/omnes-capital) — Series A, Series B
- Debiopharm Group — Series A
- AXA Venture Partners (https://capitalatlas.ai/funds/axa-venture-partners) — Series B
- Debiopharm Innovation Fund (https://capitalatlas.ai/funds/debiopharm-innovation-fund) — Series B
- Yaday (https://capitalatlas.ai/funds/yaday) — Series B
- Blast.Club (https://capitalatlas.ai/funds/blast-club) — Series B